Dengue: Status of current and under‐development vaccines

@article{Redoni2020DengueSO,
  title={Dengue: Status of current and under‐development vaccines},
  author={Marianna Redoni and S. Yacoub and L. Rivino and D. Giacobbe and R. Luzzati and S. Di Bella},
  journal={Reviews in Medical Virology},
  year={2020},
  volume={30}
}
Dengue is an emerging mosquito‐borne viral infection with increasing reports of outbreaks. The clinical picture ranges from a benign febrile illness through to severe and potentially fatal manifestations. No specific anti‐viral treatment exists, and therapy only consists of supportive care. During the last three decades, several attempts to develop an effective vaccine have been made. The first dengue vaccine to obtain licensure was Dengvaxia, which was authorized in 2015 and is currently… Expand
16 Citations
Dengue vaccine development by the year 2020: challenges and prospects
  • 1
Covid‐19 and dengue: Double punches for dengue‐endemic countries in Asia
  • 10
...
1
2
...

References

SHOWING 1-10 OF 77 REFERENCES
Dengue vaccine: Global development update.
  • 16
  • PDF
Dengue vaccines: recent developments, ongoing challenges and current candidates
  • 66
Working towards dengue as a vaccine-preventable disease: challenges and opportunities
  • 8
Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development
  • 11
Dengue Fever: Causes, Complications, and Vaccine Strategies
  • 63
  • PDF
Dengue: a growing threat requiring vaccine development for disease prevention
  • 14
Efficacy of a tetravalent dengue vaccine in children in Latin America.
  • 713
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
  • 71
Animal models for dengue vaccine development and testing
  • 7
  • PDF
...
1
2
3
4
5
...